logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
G

Gavin Koh

generate:biomedicines
H指数:29
被引数:3,161

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Randomized, Double-Blind, Placebo-Controlled First-in-Human Trial of a First-in-Class AI-Designed Monoclonal Antibody (GB-0669) Against the Conserved SARS-CoV-2 Spike S2 Stem Helix

随机、双盲、安慰剂对照的首次人体临床试验：一类AI设计的单克隆抗体（GB-0669）针对保守的SARS-CoV-2刺突S2茎螺旋

The Journal of Infectious Diseases
IF0
2026-07-140
PRE
Francesco Borriello; Gavin C K W Koh; Iñaki F Troconiz; Rounak Nassirpour; Lovely Goyal; Anvar Suyundikov; Akber Safder; Nicholas Robertson; Anna Allen; Andrew Robertson; Stephanie Straley; Pam Farmer; Denise Murphy; Eric Carlin; Kimberly P Schmitt; Amarendra Pegu; Daria Hazuda; Alexandra Snyder; Dinesh P De Alwis
Lineage-informative microhaplotypes for recurrence classification and spatio-temporal surveillance of Plasmodium vivax malaria parasites
NATURE COMMUNICATIONS
IF15.7
2024-08-083
OAAI
Siegel, Sasha V.; Trimarsanto, Hidayat; Amato, Roberto; Murie, Kathryn; Taylor, Aimee R.; Sutanto, Edwin; Kleinecke, Mariana; Whitton, Georgia; Watson, James A.; Imwong, Mallika; Assefa, Ashenafi; Rahim, Awab Ghulam; Nguyen, Hoang Chau; Tran, Tinh Hien; Green, Justin A.; Koh, Gavin C. K. W.; White, Nicholas J.; Day, Nicholas; Kwiatkowski, Dominic P.; Rayner, Julian C.; Price, Ric N.; Auburn, Sarah
A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trial
NATURE MEDICINE
IF50
2024-02-166
OAAI
Diacon, Andreas H.; Barry, Clifton E., III; Carlton, Alex; Chen, Ray Y.; Davies, Matt; de Jager, Veronique; Fletcher, Kim; Koh, Gavin C. K. W.; Kontsevaya, Irina; Heyckendorf, Jan; Lange, Christoph; Reimann, Maja; Penman, Sophie L.; Scott, Rhona; Maher-Edwards, Gareth; Tiberi, Simon; Vlasakakis, Georgios; Upton, Caryn M.; Aguirre, David Barros
Breakthrough SARS-CoV-2 Infections in the PROVENT Prevention Trial Were Not Associated With AZD7442 (Tixagevimab/Cilgavimab) Resistant Variants

PROVENT预防试验中的突破性SARS-CoV-2感染与AZD7442 (Tixagevimab/Cilgavimab) 耐药变体无关

JOURNAL OF INFECTIOUS DISEASES
IF4.5
2023-06-062
OAAI
Tuffy, Kevin M.; Ahani, Bahar; Aksyuk, Anastasia A.; Avila, Miles; Brady, Tyler; Kijak, Gustavo H.; Koh, Gavin; Levin, Myron J.; Roe, Tiffany L.; Schuko, Nicolette; Thissen, Jesse; Ustianowski, Andrew; Zhang, Tianhui; Kelly, Elizabeth J.; Streicher, Katie
A molecular barcode and web-based data analysis tool to identify imported Plasmodium vivax malaria
COMMUNICATIONS BIOLOGY
IF5.1
2022-12-2310
OAAI
Trimarsanto, Hidayat; Amato, Roberto; Pearson, Richard D.; Sutanto, Edwin; Noviyanti, Rintis; Trianty, Leily; Marfurt, Jutta; Pava, Zuleima; Echeverry, Diego F.; Lopera-Mesa, Tatiana M.; Montenegro, Lidia M.; Tobon-Castano, Alberto; Grigg, Matthew J.; Barber, Bridget; William, Timothy; Anstey, Nicholas M.; Getachew, Sisay; Petros, Beyene; Aseffa, Abraham; Assefa, Ashenafi; Rahim, Awab G.; Chau, Nguyen H.; Hien, Tran T.; Alam, Mohammad S.; Khan, Wasif A.; Ley, Benedikt; Thriemer, Kamala; Wangchuck, Sonam; Hamedi, Yaghoob; Adam, Ishag; Liu, Yaobao; Gao, Qi; Sriprawat, Kanlaya; Ferreira, Marcelo U.; Laman, Moses; Barry, Alyssa; Mueller, Ivo; Lacerda, Marcus V. G.; Llanos-Cuentas, Alejandro; Krudsood, Srivicha; Lon, Chanthap; Mohammed, Rezika; Yilma, Daniel; Pereira, Dhelio B.; Espino, Fe E. J.; Chu, Cindy S.; Velez, Ivan D.; Namaik-larp, Chayadol; Villegas, Maria F.; Green, Justin A.; Koh, Gavin; Rayner, Julian C.; Drury, Eleanor; Goncalves, Sonia; Simpson, Victoria; Miotto, Olivo; Miles, Alistair; White, Nicholas J.; Nosten, Francois; Kwiatkowski, Dominic P.; Price, Ric N.; Auburn, Sarah
AZD7442 (Tixagevimab/Cilgavimab) for Post-Exposure Prophylaxis of Symptomatic Coronavirus Disease 2019

AZD7442 (Tixagevimab/Cilgavimab) 用于症状性冠状病毒疾病的暴露后预防2019

CLINICAL INFECTIOUS DISEASES
IF7.3
2022-11-2228
OAAI
Levin, Myron J.; Ustianowski, Andrew; Thomas, Steven; Templeton, Alison; Yuan, Yuan; Seegobin, Seth; Houlihan, Catherine F.; Menendez-Perez, Ibrahim; Pollett, Simon; Arends, Rosalinda H.; Beavon, Rohini; Dey, Kanika; Garbes, Pedro; Kelly, Elizabeth J.; Koh, Gavin C. K. W.; Ivanov, Stefan; Near, Karen A.; Sharbaugh, Audrey; Streicher, Katie; Pangalos, Menelas N.; Esser, Mark T.
Efficacy and safety of intramuscular administration of tixagevimab-cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial
LANCET RESPIRATORY MEDICINE
IF32.8
2022-10-01157
OAAI
Montgomery, Hugh; Hobbs, F. D. Richard; Padilla, Francisco; Arbetter, Douglas; Templeton, Alison; Seegobin, Seth; Kim, Kenneth; Campos, Jesus Abraham Simon; Arends, Rosalinda H.; Brodek, Bryan H.; Brooks, Dennis; Garbes, Pedro; Jimenez, Julieta; Koh, Gavin C. K. W.; Padilla, Kelly W.; Streicher, Katie; Viani, Rolando M.; Alagappan, Vijay; Pangalos, Menelas N.; Esser, Mark T.
Intramuscular AZD7442 (Tixagevimab-Cilgavimab) for Prevention of Covid-19

肌内注射AZD7442 (tixagevimab-cilgavimab) 预防新型冠状病毒肺炎

NEW ENGLAND JOURNAL OF MEDICINE
IF78.5
2022-06-09509
OAAI
Levin, Myron J.; Ustianowski, Andrew; De Wit, Stephane; Launay, Odile; Avila, Miles; Templeton, Alison; Yuan, Yuan; Seegobin, Seth; Ellery, Adam; Levinson, Dennis J.; Ambery, Philip; Arends, Rosalinda H.; Beavon, Rohini; Dey, Kanika; Garbes, Pedro; Kelly, Elizabeth J.; Koh, Gavin C. K. W.; Near, Karen A.; Padilla, Kelly W.; Psachoulia, Konstantina; Sharbaugh, Audrey; Streicher, Katie; Pangalos, Menelas N.; Esser, Mark T.
Provider and household costs of Plasmodium vivax malaria episodes: a multicountry comparative analysis of primary trial data
BULLETIN OF THE WORLD HEALTH ORGANIZATION
IF5.7
2019-09-2710
OAAI
Devine, Angela; Pasaribu, Ayodhia P.; Teferi, Tedlla; Pham, Huong-Thu; Awab, Ghulam Rahim; Contantia, Febrina; Thuy-Nhien Nguyen; Viet-Thanh Ngo; Tinh-Hien Tran; Hailu, Asrat; Gilchrist, Kim; Green, Justin A.; Koh, Gavin C. K. W.; Thriemer, Kamala; Taylor, Walter R. J.; Day, Nicholas P. J.; Price, Ric N.; Lubell, Yoel
Randomized Placebo-Controlled Trial Evaluating the Ophthalmic Safety of Single-Dose Tafenoquine in Healthy Volunteers
DRUG SAFETY
IF3.8
2019-06-1111
OAAI
Ackert, Jessica; Mohamed, Khadeeja; Slakter, Jason S.; El-Harazi, Sherif; Berni, Alessandro; Gevorkyan, Hakop; Hardaker, Elizabeth; Hussaini, Azra; Jones, Sion W.; Koh, Gavin C. K. W.; Patel, Jyoti; Rasmussen, Scott; Kelly, Deborah S.; Baranano, David E.; Thompson, John T.; Warren, Keith A.; Sergott, Robert C.; Tonkyn, John; Wolstenholme, Allen; Coleman, Hanna; Yuan, Alex; Duparc, Stephan; Green, Justin A.
Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria
NEW ENGLAND JOURNAL OF MEDICINE
IF78.5
2019-01-17185
OAAI
Lacerda, M. V. G.; Llanos-Cuentas, A.; Krudsood, S.; Lon, C.; Saunders, D. L.; Mohammed, R.; Yilma, D.; Batista Pereira, D.; Espino, F. E. J.; Mia, R. Z.; Chuquiyauri, R.; Val, F.; Casapia, M.; Monteiro, W. M.; Brito, M. A. M.; Costa, M. R. F.; Buathong, N.; Noedl, H.; Diro, E.; Getie, S.; Wubie, K. M.; Abdissa, A.; Zeynudin, A.; Abebe, C.; Tada, M. S.; Brand, F.; Beck, H. -P.; Angus, B.; Duparc, S.; Kleim, J. -P.; Kellam, L. M.; Rousell, V. M.; Jones, S. W.; Hardaker, E.; Mohamed, K.; Clover, D. D.; Fletcher, K.; Breton, J. J.; Ugwuegbulam, C. O.; Green, J. A.; Koh, G. C. K. W.
Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria
NEW ENGLAND JOURNAL OF MEDICINE
IF78.5
2019-01-17156
OAAI
Llanos-Cuentas, A.; Lacerda, M. V. G.; Hien, T. T.; Velez, I. D.; Namaik-Iarp, C.; Chu, C. S.; Villegas, M. F.; Val, F.; Monteiro, W. M.; Brito, M. A. M.; Costa, M. R. F.; Chuquiyauri, R.; Casapia, M.; Nguyen, C. H.; Aruachan, S.; Papwijitsil, R.; Nosten, F. H.; Bancone, G.; Angus, B.; Duparc, S.; Craig, G.; Rousell, V. M.; Jones, S. W.; Hardaker, E.; Clover, D. D.; Kendall, L.; Mohamed, K.; Koh, G. C. K. W.; Wilches, V. M.; Breton, J. J.; Green, J. A.

研究方向

暂未获取到该数据
J
Justin A. Green
H 指数:27论文数:72被引数:2,593
W
W. Joost Wiersinga
H 指数:73论文数:466被引数:5.1万
N
Nicholas Day
H 指数:120论文数:4,667被引数:8.0万
S
Sharon J. Peacock
H 指数:114论文数:708被引数:6.6万
T
Tom van der Poll
H 指数:138论文数:1,232被引数:11.7万
S
Stephan Duparc
H 指数:41论文数:123被引数:6,219
A
Alejandro Llanos‐Cuentas
H 指数:57论文数:319被引数:9,922
M
Marcus Lacerda
H 指数:69论文数:653被引数:2.0万
N
Nicholas J. White
H 指数:186论文数:2,043被引数:13.8万
D
Direk Limmathurotsakul
H 指数:69论文数:451被引数:3.2万